Netanyahu campaigns with a friend behind him. Photo: Artur Widak/NurPhoto via Getty Images

Israeli Prime Minister Benjamin Netanyahu enters Israel's third elections in 10 months with momentum — and with his corruption trial looming just two weeks after the vote.

Why it matters: Israeli politics have been deadlocked for nearly a year as Netanyahu and his centrist rival, Benny Gantz, grapple for power. Monday's vote could provide the breakthrough, or set Israel on course for yet another election.

Where things stand: Netanyahu's Likud party has taken a narrow lead in recent polls, ahead of Gantz's Blue and White, which had previously led most polls since September.

  • Netanyahu's recent trips to Washington, for the unveiling of President Trump's peace plan, and Moscow, to secure the release of an Israeli woman held on drug charges, helped boost the prime minister's image as a foreign policy maestro.
  • At the same time, Netanyahu ended his quest for parliamentary immunity from the three corruption indictments against him. That deprived Gantz of the central issue driving his campaign, as he'd plan to focus his electoral push around Netanyahu's immunity hearings.
  • Netanyahu's approval ratings have also pulled ahead of Gantz's, which slid in recent weeks.

What to watch: Netanyahu is seeking a right-wing majority in the Knesset, Israel's 120-member parliament. With 61 seats, his political bloc could disrupt the legal proceedings or at least allow him to continue as prime minister during the trial.

  • The latest polls project that the right-wing bloc will win one seat more than Gantz's center-left bloc, but that neither will gain a majority.
  • Gantz has ruled out a unity government, saying he won't negotiate with Netanyahu due to the corruption trial.
  • Barring a surprise result, a fourth election is likely.

Either way, on March 17 Netanyahu's battle for survival will move from the ballot box to the courthouse.

Go deeper: Israel cancels academic's lectures for criticizing Netanyahu's Iran policy

Go deeper

Dan Primack, author of Pro Rata
56 mins ago - Economy & Business

GoodRx prices IPO at $33 per share, valued at $12.7 billion

Illustration: Sarah Grillo/Axios

GoodRx, a price comparison app for prescription drugs at local pharmacies, on Tuesday night raised $1.14 billion in its IPO, Axios has learned.

By the numbers: GoodRx priced its shares at $33 a piece, above its $24-$28 per share offering range, which will give it an initial market cap of around $12.7 billion.

Updated 57 mins ago - Politics & Policy

House Democrats and Trump admin strike deal to avert government shutdown

House Speaker Nancy Pelosi on Capitol Hill. Photo: Tom Williams/CQ-Roll Call via Getty Images

The House on Tuesday passed legislation to fund the government through Dec. 11, by a vote of 359-57.

Why it matters: The bill will avert a government shutdown when funding expires in eight days. Pelosi and House Majority Leader Steny Hoyer (D-Md.) said earlier that they hoped to hold a vote on the legislation on Tuesday evening.

Scoop: Meadows puts agencies on notice about staff shake-up

Internal government email obtained by Axios

White House chief of staff Mark Meadows told administration officials Monday to expect senior aides to be replaced at many government agencies, according to an internal email obtained by Axios.

Behind the scenes: Meadows asked the director of the White House Presidential Personnel Office John McEntee "to look at replacing the White House Liaisons (WHLs) at many of your agencies," according to the email. "John will be working with outgoing liaisons to explore other opportunities."

Get Axios AM in your inbox

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Subscription failed
Thank you for subscribing!